Recombinant SARS-Cov-2 Spike S1 protein (D614G), His & Avi (HEK293)
重组SARS冠状病毒2 Spike突变蛋白S1 (D614G)(His-Avi)
英文名称 | Recombinant SARS-Cov-2 Spike S1 protein (D614G), His & Avi (HEK293) |
中文名称 | 重组SARS冠状病毒2 Spike突变蛋白S1 (D614G)(His-Avi) |
别 名 | SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2; 2019-nCOV Spike S1(D614G), Recombinant (His-Avi Tag); Recombinant SARS-Cov-2 Spike S1 protein (D614G), His & Avi (HEK293) 突变型新冠蛋白; 新冠病毒S蛋白突变体(D614G); 重组新冠病毒 Spike突变蛋白RBD(D614G); 新型冠状病毒Spike突变体蛋白; |
理论分子量 | 77.9kDa |
检测分子量 | 110-130 kDa |
性 状 | Lyophilized or Liquid |
浓 度 | >0.5 mg/ml |
物 种 | SARS-Cov-2 |
序 列 | 14-683/1273 |
纯 度 | >95% as determined by SDS-PAGE |
纯化方法 | AC |
内毒素 | Not analyzed |
表达系统 | HEK293 cell |
活性 | Yes |
标签 | His & Avi |
缓 冲 液 | Lyophilized from 0.22 um filtered solution in PBS (pH=7.4). Normally 5% trehalose is added as protectant before lyophilization. |
保存条件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
产品介绍 | The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct |
本产品仅供科研使用.请勿用于医药,不能用于临床治疗诊断使用!